This invention relates to novel peptidomimetic compounds which are useful as linkers of antibody-drug conjugates (ADC). This invention also relates to ADCs containing peptidomimetic linkers and anthracycline derivatives. It is contemplated that the ADC of the present invention may be used to treat various diseases or disorders, e.g.characterised by the overexpression of a tumour antigen.Esta invención se refiere a ligadores peptidomiméticos y conjugados de anticuerpo-fármaco de los mismos, a composiciones farmacéuticas que los contienen, y a su uso en terapia para la prevención o tratamiento de cáncer.
